Videos

Viktor Grunwald, MD, PhD, discusses the post-hoc analysis of the phase 3 CLEAR trial investigating the combination treatment in the first-line setting for advanced renal cell carcinoma.

Atta Chowdhry, RPh, discusses treatment approaches for acute episodes and prophylaxis in patients with hemophilia A.

Robert Sidonio Jr, MD, MSc, discusses patient-centered therapy choices, highlighting the diverse options and considerations for hemophilia A treatment.

Rimple Gabri, PharmD, a pharmacist with Giant Pharmacy for nearly 3 decades, shares her journey into the pharmacy profession.

Taking pharmacists out of the dispensing setting and placing them in communities as educators on drug safety is reaping rewards.

Vanessa Campbell, PharmD, the director of Clinical Pharmacy at UPMC Health Plan, discusses her role and responsibilities, which include managing a team of pharmacists involved in patient outreach and clinical disease state management.

Saira A. Jan, MS, PharmD, discussed a novel pilot program in New Jersey aiming to expand home infusion services in oncology.

Thrifty White has created a newsletter sharing the impacts their pharmacists have on patients, including one pharmacist who recognized stroke symptoms and was able to get the patient help.

Mike Schuh, PharmD, MBA, FAPhA, FFSHP, a medication management pharmacist at the Mayo Clinic in Florida, discusses his journey into the pharmacy profession and the evolution of pharmacists from product-oriented to clinical professionals.

Erica Marchese, PharmD, MHA, BCPS, BCOP, BCSCP, discussed the revision of pharmacy and the contributing roles within the pharmacy team.

In her final discussion, Dr Moore analyzes key differences between the NATALEE and moncarchE trials.

Jacob Kettle, PharmD, BCOP, joins Drs Haumschild and DiMarco in a conversation surrounding findings from the SONIA trial and their impact on shifting mBC treatment strategies.

Expert panelists discuss the impact of CDK4/6 inhibitor therapy on progression-free and overall survival.

Timothy O’Shea, MS, PharmD, discussed the growth of home infusion programs and how they benefit patients.

In addition to celebrating his colleagues, Medrano said he is taking more time for mindfulness and meditation before going to work each day.

Christina Madison, PharmD, FCCP, AAHIVP, sat down with Amy Marie Merrell, to discuss current issues within sexual health.

The assistant program director at Mayo Clinic discusses the significance of pharmacists’ role in health care, changes throughout the industry, and her passion for mentoring pharmaceutical students.

Kimberly Maxfield, PhD, discussed pharmacist’s role to aid patients when switching to a biosimilar

In this field, Marshall notes that pharmacists can help by building forecasts and assist with managing members’ care before and after gene therapy.

Lisa Schrade, PharmD, discusses factor replacement therapies and emicizumab’s role in treating hemophilia.

Experts explore the impact of hemophilia on patients’ lives, economic impact, and the crucial role of specialty pharmacists.

Jensen notes that although she expects there will be a lot of FDA approvals in 2023 and 2024, there likely will not be another biosimilar “boom” until 2025.

Jeff J, Mclntyre, MA, Vice President of Liver Health Programs, Global Liver Institute, discussed the clinical and economic burden of NASH

Medically integrated dispensing specialty pharmacies can connect patient medical and pharmacy records to improve medication adherence and help patients to safely stay on them for longer.

Grace Yun, PharmD, and pharmacy manager at St. Francis Hospital, discussed the value of the pharmacist and how she sees the future of pharmacy evolving.

A specialist in adult, child, and adolescent psychiatry discusses the challenges in ADHD treatment for both patients and providers, as well as insights from a recent survey of health care professionals.

In the clinical setting, psychedelic medicine has promise as a safe and efficacious treatment for PTSD, TBIs, and other mental health issues.

These pharmacies can use electronic medical records to work more directly with providers, monitoring adverse medication effects and assessment schedules and being more tuned into patient needs.

Kimberly Westrich, MA, discussed value assessment tools and how they can help make key decisions in health care spending.

Laura Chambers, DO, drives a conversation surrounding the impact of misinformation on gynecologic cancers that is spread through social media.